The Phase IIa study will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with FXS, the most common form of inherited intellectual disability without a specific treatment
Read moreResults of exploratory research from the open-label phase III INTRIGUE clinical trial demonstrate the potential utility of circulating tumor DNA (ctDNA) next-generation sequencing (NGS)-based analysis...
Read moreEl Instituto de Investigación Sanitaria La Fe (IIS La Fe) ha puesto en marcha un ensayo clÃnico para mejorar la supervivencia de pacientes diagnosticados con neuroblastoma de alto riesgo en España ...
Read moreThe new immunotherapy is based on the so-called STAb cells. It has yet to pass clinical trials and therefore it will be at least two years before it reaches the patients.
Read moreThe Ministry of Science, Innovation and Universities and the European Union, through the Next Generation EU program will finance this new phase. It will evaluate the efficacy of CTH120 as an innovativ...
Read moreUn estudio propone un novedoso enfoque para frenar la degeneración neuromuscular en pacientes con Esclerosis Lateral Amiotrófica (ELA). Esta patologÃa provoca la pérdida de neuronas motoras y la p...
Read moreEl Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND) se consolida como uno de los lÃderes en el ámbito nacional en investigación en salud. MÃ...
Read moreNorthSea Therapeutics B.V. today announced the dosing of the first patient in its Phase 2a clinical trial of Orziloben (NST-6179) in intestinal failure-associated liver disease (IFALD), an orphan live...
Read moreTheir primary goal is securing the necessary funding to propel the testing of our lead compound, volasertib, in five types of pediatric cancer (Ewing’s sarcoma, alveolar rhabdomyosarcoma, medullobla...
Read moreyzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the fourth quar...
Read moreA clinical trial analyzed the influence of albumin on the development of acute kidney injury associated with cardiac surgery under extracorporeal circulation (ECC) in patients with preserved preopera...
Read moreARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs backed by Columbus Venture Partners, has announced that the ...
Read more